Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.

Alapat D, Coviello-Malle J, Owens R, Qu P, Barlogie B, Shaughnessy JD, Lorsbach RB.

Am J Clin Pathol. 2012 Jan;137(1):93-100. doi: 10.1309/AJCP59UORCYZEVQO.

2.

Immunophenotypic stability of CD200 expression in plasma cell myeloma.

Olteanu H, Harrington AM, Kroft SH.

Am J Clin Pathol. 2012 Jun;137(6):1013-4. doi: 10.1309/AJCP8TF3WUIWLZHU. No abstract available.

PMID:
22586062
3.

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.

Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, Conticello C, Villari L, Di Raimondo F.

Leuk Res. 2009 Sep;33(9):1212-6. doi: 10.1016/j.leukres.2009.01.017. Epub 2009 Feb 20.

PMID:
19230971
4.

CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.

Sandes AF, de Lourdes Chauffaille M, Oliveira CR, Maekawa Y, Tamashiro N, Takao TT, Ritter EC, Rizzatti EG.

Cytometry B Clin Cytom. 2014 Mar;86(2):98-105. doi: 10.1002/cyto.b.21128. Epub 2013 Oct 8.

5.

Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.

Wasik AM, Priebe V, Lord M, Jeppsson-Ahlberg Å, Christensson B, Sander B.

Leuk Lymphoma. 2015 May;56(5):1425-31. doi: 10.3109/10428194.2014.953147. Epub 2014 Oct 7.

PMID:
25120048
6.

Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.

Lesesve JF, Tardy S, Frotscher B, Latger-Cannard V, Feugier P, De Carvalho Bittencourt M.

Int J Lab Hematol. 2015 Aug;37(4):486-94. doi: 10.1111/ijlh.12315. Epub 2014 Dec 3.

PMID:
25470765
7.

Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.

Fan L, Miao Y, Wu YJ, Wang Y, Guo R, Wang L, Shen AL, Chen YY, Xu W, Li JY.

Leuk Lymphoma. 2015;56(12):3329-35. doi: 10.3109/10428194.2015.1030642. Epub 2015 Jun 19.

PMID:
25791119
8.
9.

Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.

Carreras J, Villamor N, Colomo L, Moreno C, Ramón y Cajal S, Crespo M, Tort F, Bosch F, López-Guillermo A, Colomer D, Montserrat E, Campo E.

J Pathol. 2005 Mar;205(4):507-13.

PMID:
15685592
10.

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.

Mikaelsson E, Danesh-Manesh AH, Lüppert A, Jeddi-Tehrani M, Rezvany MR, Sharifian RA, Safaie R, Roohi A, Osterborg A, Shokri F, Mellstedt H, Rabbani H.

Blood. 2005 Jun 15;105(12):4828-35. Epub 2005 Mar 1.

11.

CD200 Expression on Plasma Cell Myeloma Cells is Associated with the Efficacies of Bortezomib, Lenalidomide and Thalidomide.

Tazawa S, Shiozawa E, Homma M, Arai N, Kabasawa N, Kawaguchi Y, Fujiwara S, Okino K, Kobayashi K, Yamochi T, Tate G, Nakamaki T, Takimoto M.

J Clin Exp Hematop. 2015;55(3):121-6. doi: 10.3960/jslrt.55.121.

12.

Expression of LEF1 in mantle cell lymphoma.

O'Malley DP, Lee JP, Bellizzi AM.

Ann Diagn Pathol. 2017 Feb;26:57-59. doi: 10.1016/j.anndiagpath.2016.09.016. Epub 2016 Nov 22. Review.

PMID:
28038713
13.

Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.

Alley CL, Wang E, Dunphy CH, Gong JZ, Lu CM, Boswell EL, Burchette J, Lagoo AS.

Arch Pathol Lab Med. 2013 Apr;137(4):503-17. doi: 10.5858/arpa.2011-0696-OA. Review.

PMID:
23544940
14.

CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.

Gong S, Osei ES, Kaplan D, Chen YH, Meyerson H.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1613-21. eCollection 2015.

15.
16.

CD200 (OX-2 membrane glycoprotein) expression in b cell-derived neoplasms.

Dorfman DM, Shahsafaei A.

Am J Clin Pathol. 2010 Nov;134(5):726-33. doi: 10.1309/AJCP38XRRUGSQOVC.

PMID:
20959655
17.

Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging.

Challagundla P, Medeiros LJ, Kanagal-Shamanna R, Miranda RN, Jorgensen JL.

Am J Clin Pathol. 2014 Dec;142(6):837-44. doi: 10.1309/AJCPBV9ELXC0ECVL.

PMID:
25389338
18.
19.

Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.

McCarron KF, Hammel JP, Hsi ED.

Am J Clin Pathol. 2000 Jun;113(6):805-13. Erratum in: Am J Clin Pathol 2000 Sep;114(3):489.

PMID:
10874881
20.

CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.

Sandes AF, de Lourdes Chauffaille M, Oliveira CR, Maekawa Y, Tamashiro N, Takao TT, Ritter EC, Rizzatti EG.

Cytometry B Clin Cytom. 2013 Aug 29. doi: 10.1002/cytob.21128. [Epub ahead of print]

Supplemental Content

Support Center